Abstract: The present invention relates to a method of simulating an indoor behavior of a pesticidal compound, and aims to provide a simulation method which can process simultaneous differential equations necessary for simulation accurately in a short time, and to evaluate safety of the compound with respect to a human body. The simulation method includes a step of dividing an indoor environment into predetermined media and forming a differential equation concerning a fugacity of the compound in each of the media; a step of determining the fugacity of the compound in each of the media from the differential equation; a step of determining the indoor behavior of the compound from the fugacity of the compound in each of the media; a step of changing, in response to a fluctuation in mass balance of the compound indoors, a minute time unit used when solving the differential equation; and a step of evaluating, according to the indoor behavior of the compound, safety of the compound with respect to the human body.
Abstract: An automated modeler for modeling of an interactive system comprising at least one biological entity and at least one pharmaceutical substance, the system comprising, a representation of states of said system, a knowledge tree builder, associated with said representation for allowing users to define the states, expected relationships between said states and independent inputs to the states, and a data miner associated with said representation to operate on data taken from said system to apply said data to said states in accordance with said defined relationships and inputs, thereby to apply numerical values to said relationships and said inputs, thereby to model said interactions.
Abstract: The present invention provides methods for enhanced detection of biological response profiles. In particular, the methods of this invention allow for the detection of biological response patterns, such as gene expression patterns, in response to different drug treatments. The methods of the invention also allow the determination of a “consensus profile” which describes a particular class or type of biological response. In certain embodiments the consensus profile may describe the biological response of a particular group or class of drugs. In other embodiments, the consensus profile may describe an “ideal” biological response such as one associated with a desired therapeutic effect. The methods of the present invention also allow for the comparison of different biological responses. Thus, the methods of the invention may be used, e.g., to identify and/or study new drugs.
Type:
Grant
Filed:
December 23, 1998
Date of Patent:
October 5, 2004
Assignee:
Rosetta Inpharmatics LLC
Inventors:
Stephen H. Friend, Roland Stoughton, Yudong He
Abstract: The invention provides methods for diagnosing cancer including colon cancer, based on the identification of certain colon cancer-associated polypeptides as antigens that elicit immune responses in colon cancer. The identified antigens can be utilized as markers for diagnosing colon cancer, and for following the course of treatment of colon cancer.
Type:
Grant
Filed:
May 4, 2001
Date of Patent:
September 21, 2004
Assignees:
Ludwig Institute for Cancer Research, Cornell Research Foundation, Inc.
Inventors:
Yao-Tseng Chen, Lloyd J. Old, Matthew J. Scanlan, Elisabeth Stockert
Abstract: The present invention relates to novel genes located in two chromosomal regions within uropathogenic E. coli that are associated with virulence. These chromosomal regions are known as pathogenicity islands (PAIs). In particular, the present application discloses 142 sequenced fragments (contigs) of DNA from two pools of cosmids covering pathogenicity islands PAI IV and PAI V located on the chromosome of the uropathogenic Escherichia coli J96. Further disclosed are 351 predicted protein-coding open reading frames within the sequenced fragments.
Type:
Grant
Filed:
September 20, 2001
Date of Patent:
September 7, 2004
Assignees:
Human Genome Sciences, Inc., Wisconsin Alumni Research Foundation
Inventors:
Patrick J. Dillon, Gil H. Choi, Rodney A. Welch
Abstract: A thermal cycling method and device is disclosed. The device comprises a sample chamber whose temperature can be rapidly and accurately modulated over a range of temperatures needed to carry out a number of biological procedures, such a the DNA polymerase chain reaction. Biological samples are placed in glass micro capillary tubes and then located inside the sample chamber. A programmable controller regulates the temperature of the sample inside the sample chamber. Once a heating cycle is completed, the controller opens a door to the chamber for venting hot air out and cool ambient air is moved in. Temperature versus time profiles corresponding to optimum denaturation, annealing and elongation temperatures for amplification of DNA are achieved by the present invention.
Abstract: A technique is disclosed that is useful for determining the presence of specific hybridization expression within an output pattern generated from a digitized image of a biological sample applied to an arrayed platform. The output pattern includes signals associated with noise, and signals associated with the biological sample, some of which are degraded or obscured by noise. The output pattern is first segmented using tessellation. Signal processing, such as interferometry, or more specifically, resonance interferometry, and even more specifically quantum resonance interferometry or stochastic resonance interferometry, is then used to amplify signals associated with the biological sample within the segmented output pattern having an intensity lower than the intensity of signals associated with noise so that they may be clearly distinguished from background noise. The improved detection technique allows repeatable, rapid, reliable, and inexpensive measurements of arrayed platform output patterns.
Abstract: The present invention provides a hybridization detection method capable of quantitatively determining the degree of the hybridization between a sample biopolymer and a probe biopolymer. In the method, the amount of a fluorescently labeled probe immobilized on a substrate as a spot is quantitatively determined by determining the fluorescence emitted from a fluorescent material labeling the probe, and the amount of a fluorescently labeled sample hybridized to the probe is quantitatively determined by determining the fluorescence emitted from the fluorescent material labeling the sample. The difference between the amount of the probe and the amount of the sample is normalized with the amount of the probe. Based on the normalized value, the amount of the sample hybridized to the probe can be determined relative to the amount of the probe spotted on the substrate.
Abstract: Peptide nucleic acids and analogues of peptide nucleic acids are used to form duplex, triplex, and other structures with nucleic acids and to modify nucleic acids. The peptide nucleic acids and analogues thereof also are used to modulate protein activity through, for example, transcription arrest, transcription initiation, and site specific cleavage of nucleic acids.
Type:
Grant
Filed:
November 16, 1999
Date of Patent:
August 3, 2004
Assignees:
ISIS Pharmaceuticals, Inc.
Inventors:
David J. Ecker, Ole Buchardt, Michael Egholm, Peter E. Nielsen, Rolf H. Berg, Niels E. Mollegaard
Abstract: This invention relates to a metal complex of formula (I). The metal complex is capable of cleaving a bulge-containing nucleic acid at the bulge site with high specificity.
Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Candida albicans that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from fungal infection.
Abstract: A system for acquiring knowledge from cellular information. The system has a database comprising a database management module (“DBMS”). The system also has a variety of modules, including a population module coupled to the DBMS for categorizing and storing a plurality of features (e.g., cell size, distance between cells, cell population, cell type) from an image acquisition device into the database. The system has a translation module coupled to the DBMS for defining a descriptor from a set of selected features from the plurality of features. In a specific embodiment, the descriptor is for a known or unknown compound, e.g., drug. A prediction module is coupled to the DBMS for selecting one of a plurality of a descriptors from known and unknown compounds from the database based upon a selected descriptor from a selected compound. The selected compound may be one that is useful for treatment of human beings or the like.
Type:
Grant
Filed:
May 14, 1999
Date of Patent:
June 1, 2004
Assignee:
Cytokinetics, Inc.
Inventors:
James H. Sabry, Cynthia L. Adams, Eugeni A. Vaisberg, Anne M. Crompton
Abstract: The present invention is directed to an analog, oligomer-based method for determining a mathematical result of carrying out an operation of matrix algebra on input data. The method comprises representing at least one m-component vector V=&Sgr;iViei by a set of single-stranded oligomers Ei and Ei which are in 1:1 correspondence with the basis vectors ei, i=1, 2, . . . , m in an abstract m-dimensional vector space. A composition comprising at least one set of oligomers Ei and Ei representing the components of a vector is obtained as input date and is subjected to at least one physical or chemical treatment having an effect on the oligomers that is an analog representation of an operation of matrix algebra. The method can be used to represent the operations of a neural network; for example, to produce a content-addressable memory, or a multilayer perceptron.
Type:
Grant
Filed:
August 6, 1998
Date of Patent:
May 25, 2004
Assignee:
Lucent Technologies Inc.
Inventors:
Allen P. Mills, Jr., Bernard Yurke, Philip M. Platzman
Abstract: Methods of and compositions for killing or inhibiting the growth of a bacteria are disclosed. The methods comprise the use of peptide nucleic acids that are targeted to mRNA and/or rRNA. In certain embodiments, methods include the use of one or more separate antibiotics.
Abstract: A computer system for analyzing nucleic acid sequences is provided. The computer system is used to perform multiple methods for determining unknown bases by analyzing the fluorescence intensities of hybridized nucleic acid probes. The results of individual experiments are improved by processing nucleic acid sequences together. Comparative analysis of multiple experiments is also provided by displaying reference sequences in one area and sample sequences in another area on a display device.
Type:
Grant
Filed:
March 27, 1998
Date of Patent:
May 11, 2004
Assignee:
Affymetrix Inc.
Inventors:
Mark S. Chee, Chunwei Wang, Luis C. Jevons, Derek H. Bernhart, Robert J. Lipshutz
Abstract: An electronic device for performing biological operations includes a support substrate and an array of microlocations disposed on the substrate. The array of microlocations include electronically addressable electrodes. A first collection electrode is disposed on the substrate and adjacent to a first side of the array of microlocations. A second collection electrode is disposed on the substrate and adjacent to a second side of the array of microlocations, the second side of the array being opposite of the first side such that the array of microlocations is disposed between the first and second collection electrodes. A flow cell is supported on the substrate. Preferably, the combined area of the collection electrodes is a substantial fraction, preferably at least 50% of the area of the footprint of the flow cell.
Type:
Grant
Filed:
June 19, 2000
Date of Patent:
April 27, 2004
Assignee:
Nanogen, Inc.
Inventors:
Donald E. Ackley, Paul D. Swanson, Scott O. Graham, Elizabeth L. Mather, Timothy L. LeClair, William F. Butler
Abstract: The sequences of nucleic acids encoding proteins required for E. coli proliferation are disclosed. The nucleic acids can be used to express proteins or portions thereof, to obtain antibodies capable of specifically binding to the expressed proteins, and to use those expressed proteins as a screen to isolate candidate molecules for rational drug discovery programs. The nucleic acids can also be used to screen for homologous genes that are required for proliferation in microorganisms other than E. coli. The nucleic acids can also be used to design expression vectors and secretion vectors. The nucleic acids of the present invention can also be used in various assay systems to screen for proliferation required genes in other organisms as well as to screen for antimicrobial agents.
Type:
Grant
Filed:
January 27, 2000
Date of Patent:
April 13, 2004
Assignee:
Elitra Pharmaceuticals, Inc.
Inventors:
Judith Zyskind, Kari L. Ohlsen, John Trawick, R. Allyn Forsyth, Jamie M. Froelich, Grant J. Carr, Robert T. Yamamoto, H. Howard Xu
Abstract: This invention provides a method of generating a subtracted cDNA library of a cell comprising: a) generating a cDNA library of the cell; b) isolating double-stranded DNAs from the cDNA library; c) releasing the double-stranded cDNA inserts from the double-stranded DNAs; d) denaturing the isolated double-stranded cDNA inserts; e) hybridizing the denatured double-stranded cDNA inserts with a labelled single-stranded nucleic acid molecules which are to be subtracted from the cDNA library; and f) separating the hybridized labeled single-stranded nucleic acid molecule from the double-stranded cDNA inserts, thereby generating a subtracted cDNA library of a cell. This invention also provides different uses of the subtracted library.
Type:
Grant
Filed:
December 23, 1998
Date of Patent:
April 13, 2004
Assignee:
The Trustees of Columbia University in the City of New
York
Abstract: The present invention provides arrays comprising a plurality of polynucleotide probes having sequences complementary to the 3′ untranslated region of a gene transcript, whose chromosomal location has been defined. The arrays are particularly useful for conducting comparative gene expression analyses. The present invention also includes a method of preparing these arrays and various methods of using these arrays for detecting differential expression of multiple gene transcripts amongst multiple subjects. Further provided by the invention are computer readable media recorded thereon an array of polynucleotide probes as specified herein, a computer-based system, and kits for detecting differential expression of a multiplicity of gene transcripts.
Type:
Grant
Filed:
June 9, 2000
Date of Patent:
April 6, 2004
Inventors:
Narayan Baidya, Yii-Der Ida Chen, Julie Holding, Yie-Teh Yu